Evaluation of immature myocardial energy metabolism during ischemia and after reperfusion by NMR spectroscopy
核磁共振波谱法评估缺血期间和再灌注后未成熟心肌的能量代谢
基本信息
- 批准号:03454339
- 负责人:
- 金额:$ 3.65万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1991
- 资助国家:日本
- 起止时间:1991 至 1992
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Multidose infusion of crystalloid cardioplegia has been reported to be detrimental to immature myocardium by many investigators. We investigated the effect of multidose cold blood cardioplegia (CBC) on immature myocardium in comparison with St. Thomas' cardioplegia (ST). Hearts from neonatal rabbits (6-9 days) were perfused at 37 OC in the Langendorff method before and after ischemia. Myocardial viability was evaluated by NMR spectroscopy and was expressed in % of preischemic value (mean * SE). Myocardial water content was measured by the wet and dry method. Immature hearts (five in each group) received a single 10 ml infusion of each cardioplegic solution or multiple infusions ( at 15-, 30-, or 60-min.intervals ) at 15 OC during 3 hrs of ischemia. After reperfusion for 30 mins., a single dose of ST showed good recovery of ATP (91.7 * 2.6%), but more frequent infusions of ST worsened ATP recovery (63.1 * 5.0% in the 15-min. interval group,p<0.01 vs single-dose group). In contrast CBC at 15-min.intervals produced best recovery of ATP (95.1 * 3.6%), and multidose CBC infusion improved postischemic ATP recovery (75.1 * 3.7% in single-dose group, p<0.05 vs multidose groups). Myocardial water contents in ST groups were significantly higher than in CBC groups, however, they had no relationship with ATP recovery. These observations suggest that multidose cardioplegic infusion is not always detrimental to the immature heart and that the Immature heart may be more sensitive than the adult heart to the combination of cardioplegic solution and infusion method. In conclusion we have to find a suitable infusion method for the cardioplegic solution adopted.
多剂量晶体停搏液输注对未成熟心肌有损伤作用。我们研究了多剂量冷血停搏液(CBC)对未成熟心肌的作用,并与St.托马斯停搏液(ST)进行了比较。用Langendorff法于37 ℃对6-9天的新生兔心脏进行缺血前后的灌流。通过核磁共振波谱法评价心肌活力,并以缺血前值的%(平均值 * SE)表示。采用干湿法测定心肌含水量。未成熟的心脏(每组5个)在缺血3小时期间于15 ℃接受每种心脏停搏液10 ml的单次输注或多次输注(间隔15、30或60分钟)。再灌注30分钟后,ST单次给药显示ATP恢复良好(91.7 * 2.6%),但ST更频繁输注使ATP恢复恶化(15分钟间隔组为63.1 * 5.0%,p<0.01 vs单次给药组)。相反,15分钟间隔的CBC产生最佳的ATP恢复(95.1 * 3.6%),并且多剂量CBC输注改善缺血后ATP恢复(单剂量组为75.1 * 3.7%,p<0.05 vs多剂量组)。ST组心肌含水量明显高于CBC组,但与ATP恢复无关。这些观察结果表明,多剂量心脏停搏液输注并不总是有害的未成熟的心脏,未成熟的心脏可能比成人心脏更敏感的心脏停搏液和输注方法的组合。总之,我们必须找到一个合适的输注方法,心脏停搏液所采用的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATAYAMA Osamu其他文献
KATAYAMA Osamu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
- 批准号:
23K21458 - 财政年份:2024
- 资助金额:
$ 3.65万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development ofsynthetic heparin to protect liver graft from ischemia reperfusion injury duringtransplantation
开发合成肝素以保护移植肝免受移植过程中的缺血再灌注损伤
- 批准号:
10759102 - 财政年份:2023
- 资助金额:
$ 3.65万 - 项目类别:
Nanowired human isogenic cardiac organoids to treat acute myocardial ischemia/reperfusion injuries
纳米线人类同基因心脏类器官治疗急性心肌缺血/再灌注损伤
- 批准号:
10721208 - 财政年份:2023
- 资助金额:
$ 3.65万 - 项目类别:
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute Stroke
中性粒细胞在急性中风后缺血/再灌注损伤中的作用
- 批准号:
10606952 - 财政年份:2023
- 资助金额:
$ 3.65万 - 项目类别:
Efficacy of Transmaternal Human Cord Blood Cell Transplantation Therapy for Fetal Tissue Damage Caused by Ischemia-Reperfusion
经母体人脐带血细胞移植治疗缺血再灌注引起的胎儿组织损伤的疗效
- 批准号:
23K07314 - 财政年份:2023
- 资助金额:
$ 3.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Zinc Protection Against Ischemia-Reperfusion Injury in Heart
锌可预防心脏缺血再灌注损伤
- 批准号:
10652915 - 财政年份:2023
- 资助金额:
$ 3.65万 - 项目类别:
Ischemia/Reperfusion injury and Myocardial edema
缺血/再灌注损伤和心肌水肿
- 批准号:
10718260 - 财政年份:2023
- 资助金额:
$ 3.65万 - 项目类别:
Role of Gasdermin D/E in intestinal ischemia-reperfusion injury
Gasdermin D/E 在肠缺血再灌注损伤中的作用
- 批准号:
23K15529 - 财政年份:2023
- 资助金额:
$ 3.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Deficiency Of Hedgehog Interacting Protein (Hhip) In Endothelial Cells Prevents Renal Ischemia Reperfusion -Induced Renal Tubular Cell Injury via the inhibition of NF-KB signaling
内皮细胞中 Hedgehog 相互作用蛋白 (Hhip) 的缺乏可通过抑制 NF-KB 信号传导来防止肾缺血再灌注引起的肾小管细胞损伤
- 批准号:
495595 - 财政年份:2023
- 资助金额:
$ 3.65万 - 项目类别: